Money · Lobbying reports · 119th Congress
H.R. 9102
12 saved lobbying reports name H.R. 9102.
12 reports
Confirmed from the official recordSenate Office of Public Records cannot vouch for the data or analyses derived from these data after the data have been retrieved from LDA.gov.
Lobbying Disclosure Act reports, LDA.gov. This copy was read October 8, 2026 at 9:19 AM Eastern.
Reports that name this bill
The amount is what the report gives for the whole quarter: everything the registrant did for that client, all issues together. A linked name opens that organization’s page on this site.
| Registrant | Client | Amount for the whole quarter | Quarter | Filed | Report |
|---|---|---|---|---|---|
| SANOFI US SERVICES INC. | SANOFI US SERVICES INC | $920,000.00reported as expenses | April to June 2026 | Open the report | |
| AMGEN, INC. | AMGEN INC | $2,440,000.00reported as expenses | April to June 2026 | Open the report | |
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | $7,360,000.00reported as expenses | April to June 2026 | Open the report | |
| NOVARTIS | NOVARTIS | $1,410,000.00reported as expenses | April to June 2026 | Open the report | |
| FDD ACTION | FDD ACTION | $240,000.00reported as expenses | April to June 2026 | Open the report | |
| PFIZER INC. | PFIZER INC. | $1,880,000.00reported as expenses | April to June 2026 | Open the report | |
| ACADIA PHARMACEUTICALS | ACADIA PHARMACEUTICALS | $700,000.00reported as expenses | April to June 2026 | Open the report | |
| ALSTON & BIRD LLP | CURIE BIO OPERATIONS, LLC | $130,000.00reported as income | April to June 2026 | Open the report | |
| CORNERSTONE GOVERNMENT AFFAIRS, INC. | JOHNS HOPKINS UNIVERSITY | $60,000.00reported as income | April to June 2026 | Open the report | |
| TRAVERE THERAPEUTICS | TRAVERE THERAPEUTICS | $140,000.00reported as expenses | April to June 2026 | Open the report | |
| TIBER CREEK GROUP | ASTRAZENECA | $80,000.00reported as income | April to June 2026 | Open the report | |
| GSK (FKA GLAXOSMITHKLINE INC.) | GSK (FKA GLAXOSMITHKLINE INC.) | $890,000.00reported as expenses | April to June 2026 | Open the report |